BioNeutra Global Corporation announced the appointment of David W. Huber, CPA, CA as the Chief Financial Officer of the company, effective May 31, 2021. Mr. Huber will directly report to the CEO Dr. Jianhua Zhu. Mr. Huber has more than 20 years' experience in corporate finance having worked both in Canada and Internationally. He was previously the CFO of a publicly traded (TSXV) mining company and most recently worked in the insurance industry in the Cayman Islands. Mr. Huber replaces Mr. Branko Jankovic who tendered his resignation as the Chief Financial Officer effective May 31, 2021.